11 December 2025

Osteoarthritis Pharmaceuticals Rheumatology

Experts call time on discredited arthritis injection

11 December 2025

Diabetes Pharmaceuticals

Oral GLP1 hits big numbers in global trial

11 December 2025

Mental Health Pharmaceuticals

Long-term antidepressant prescribing hits record levels

11 December 2025

DMARDS Pharmaceuticals

DMARD routine bloods loosen

27 November 2025

PBAC Pharmaceuticals Rheumatology

PBAC considers major updates for rheumatology

27 November 2025

Obesity Pharmaceuticals Surgery

GLP-1s could help avoid follow-up bariatric surgery

13 November 2025

Pharmaceuticals Plaque psoriasis

Oral cytokine blockade is here

30 October 2025

Diabetes Pharmaceuticals TGA

Oral GLP-1 set for TGA submission

30 October 2025

Pharmaceuticals Urticaria

New urticaria treatment works within a week

2 October 2025

Dermatology PBAC PBS Pharmaceuticals

‘Unsustainable’: Pfizer pulls out of JAKi PBS application

4 September 2025

Pharmaceuticals

Ianalumab hits phase III milestone in Sjögren’s

7 August 2025

Dementia Pain Pharmaceuticals

Experts sound alarm on gabapentin risks

26 June 2025

Dermatitis/Eczema Pharmaceuticals

Eli Lilly pulls PBS application for eczema drug

26 June 2025

Diabetes Obesity Pharmaceuticals

Oral GLP-1RA could ‘revolutionise’ obesity management: expert

12 June 2025

Pharmaceuticals TGA

‘Major step forward’: TGA approves first pharmacological therapy for OSA

12 June 2025

cardiovascular Clinical research Pharmaceuticals Rheumatoid Arthritis

Upadacitinib outperforms adalimumab regardless of CV risk